Today: 9 June 2026
Verizon stock price ticks higher as Frontier deal closes; what VZ investors watch next
20 January 2026
1 min read

Verizon stock price ticks higher as Frontier deal closes; what VZ investors watch next

NEW YORK, Jan 20, 2026, 14:48 EST — Regular session

  • Verizon shares ticked up roughly 0.4% following the completion of its Frontier acquisition
  • SEC filing reveals Frontier shareholders will receive $38.50 in cash per share
  • Traders are now eyeing the January 30 earnings report for updates on integration and spending details

By 2:48 p.m. EST Tuesday, Verizon Communications Inc shares had risen roughly 0.4% to $39.07, following the closing of its cash acquisition of Frontier Communications Parent, according to an SEC filing. AT&T shares slipped about 0.2%, while T-Mobile US dropped around 0.6%. Frontier shareholders will receive $38.50 per share in cash, the filing stated.

The closing matters because it pushes Verizon deeper into fixed broadband, where fiber lines carry more data than older copper networks. Carriers favor bundling home internet with mobile plans since it helps reduce churn — the industry term for customers leaving.

The timing is tricky for major U.S. telecoms: promotions have returned, and investors are pressing for clarity on the balance between protecting subscribers and maintaining cash flow. Verizon’s upcoming earnings report will probably serve as the first concrete measure of how the Frontier integration is shaping up.

Chief executive Dan Schulman told employees the merger “immediately creates an unparalleled fiber network” and noted that Verizon’s coverage now extends to roughly 30 million “fiber passings”—addresses eligible for fiber service. Verizon

In September 2024, Verizon struck a deal to acquire Frontier for roughly $20 billion, debt included. California regulators gave the green light on Jan. 15, following Verizon’s agreement to specific broadband rollout and service conditions, according to Reuters.

The Frontier close comes amid renewed questions about reliability. Verizon said Tuesday that last week’s major outage was caused by a software issue and confirmed it had “no indication” of a cybersecurity attack. Downdetector recorded over 2.3 million user reports on Jan. 14, per the same report. Meanwhile, MoffettNathanson analyst Craig Moffett noted in a Tuesday memo that it’s “less clear” if Schulman will push for a faster Frontier fiber rollout while also investing heavily in wireless promotions. Broadband Breakfast

But the Frontier wager carries execution risks that defy easy summarization in a slide deck. Merging systems and field operations is a slow process, and regulatory conditions tied to approvals may force sustained capital spending if wireless price pressures persist.

Telecom investors usually focus on Verizon’s cash flow and dividend safety, not high-growth stories. So, they’re quick to react if integration expenses start climbing faster than anticipated.

Verizon plans to release its fourth-quarter 2025 earnings on Jan. 30, with a webcast set for 8:00 a.m. Eastern, the company announced. Investors will focus on guidance for 2026 spending, progress on integration efforts, and management’s take on Frontier—whether it remains a short-term cash drag or a faster route to stable broadband growth.

Verizon’s stock will probably react to any updates on integration and fresh moves by regulators investigating the outage until then.

Stock Market Today

  • Designer Brands (DBI) Beats Q1 Earnings and Revenue Estimates
    June 9, 2026, 10:04 AM EDT. Designer Brands (DBI) reported Q1 earnings of $0.07 per share, surpassing the Zacks estimate of $0.02 and reversing a year-ago loss of $0.26. Revenue hit $696.35 million, just above the $696 million consensus. The company delivered a 250% earnings surprise and has beaten EPS estimates in four consecutive quarters. Shares rose about 19.5% year-to-date, outpacing the S&P 500's 8.2% gain. Despite strong results, the stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market. The Retail - Apparel and Shoes sector ranks among the top three industries. Future stock performance will depend on management's outlook and upcoming earnings estimate revisions, with current consensus estimates at $0.30 EPS on $744 million revenue next quarter and $0.35 EPS on $2.91 billion revenue for the fiscal year.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Grab stock rises even as Wall Street slides after BofA upgrade — what’s next for GRAB
Previous Story

Grab stock rises even as Wall Street slides after BofA upgrade — what’s next for GRAB

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps
Next Story

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps

Go toTop